NCT05537454

Brief Summary

This study explores the associations between maternal stress, breastmilk composition, and feeding and neurodevelopment for preterm infants in the NICU and at 4 months corrected age.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
51mo left

Started Dec 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Dec 2022Jul 2030

First Submitted

Initial submission to the registry

September 1, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 13, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

December 9, 2022

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2030

Last Updated

September 10, 2025

Status Verified

September 1, 2025

Enrollment Period

4.6 years

First QC Date

September 1, 2022

Last Update Submit

September 9, 2025

Conditions

Outcome Measures

Primary Outcomes (13)

  • Maternal milk production inpatient

    total volume (mL)

    28-35 weeks postmenstrual age

  • Maternal milk production 4 months corrected age

    total volume (mL)

    4 months corrected age

  • Maternal milk proportion inpatient

    Proportion of maternal milk vs donor milk/formula (%)

    28-35 weeks postmenstrual age

  • Maternal milk proportion 4 months corrected age

    Proportion of maternal milk vs donor milk/formula (%)

    4 months corrected age

  • Infant Neurodevelopment inpatient

    event related potentials (ERP)

    35-37 weeks postmenstrual age

  • Infant Neurodevelopment 4 months corrected age

    event related potentials (ERP)

    4 months corrected age

  • Infant Neurodevelopment 4 months corrected age

    visual evoked potentials (VEP)

    4 months corrected age

  • Infant gut microbiome inpatient

    Microbial diversity of fecal samples

    28-35 weeks postmenstrual age

  • Infant gut microbiome 4 months corrected age

    Microbial diversity of fecal samples

    4 months corrected age

  • Milk microbiome inpatient

    Microbial diversity of milk samples

    28-35 weeks postmenstrual age

  • Milk microbiome 4 months corrected age

    Microbial diversity of milk samples

    4 months corrected age

  • Milk metabolome inpatient

    Concentration of untargeted and targeted metabolites

    28-35 weeks postmenstrual age

  • Milk metabolome 4 months corrected age

    Concentration of untargeted and targeted metabolites

    4 months corrected gestational age

Eligibility Criteria

Age28 Weeks - 34 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Early preterm infants and their mothers

You may qualify if:

  • preterm infant born between 28 0/7 and 34 6/7 weeks' gestation that are medically stable for study procedures
  • mother of preterm infant meeting criteria and a) 18 to 45 years of age at the time of delivery

You may not qualify if:

  • infants: major congenital anomalies, anticipated death, positive blood culture at birth, hypoxic ischemic encephalopathy, grade IV intraventricular hemorrhage, or plan to transfer care before discharge (35-37 weeks postmenstrual age).
  • mothers: a) alcohol consumption \>1 drink per week or any tobacco consumption during pregnancy, b) known congenital metabolic, endocrine disease or congenital illness affecting infant feeding/growth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55414, United States

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

Emily Nagel, PhD, RD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2022

First Posted

September 13, 2022

Study Start

December 9, 2022

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2030

Last Updated

September 10, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Deidentified data upon request

Time Frame
Data will be made available to other researchers no later than the acceptance for publication of the main findings from the final dataset. Depending on the volume of data requests from external researchers, a long term data sharing and preservation plan may be used to store and make publicly accessible the data beyond the life of the project.

Locations